Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ: Androgen receptor term for the estrogen receptor-bad breast cancer

Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ: Androgen receptor term for the estrogen receptor-bad breast cancer

Bieche We, Parfait B, Tozlu S, Lidereau R, Vidaud Yards: Quantitation regarding androgen receptor gene term into the sporadic nipple tumors because of the real-date RT-PCR: research one MYC was an enthusiastic AR-managed gene. Carcinogenesis. 2001, twenty-two (9): 1521-1526. /carcin/22.nine.1521.

Bratthauer GL, Lininger RA, Man YG, Tavassoli FA: Androgen and you will the hormone estrogen receptor mRNA updates in apocrine carcinomas. Diagn Mol Pathol. 2002, eleven (2): 113-118. 9606-200206000-00008.

Gatalica Z: Immunohistochemical studies from apocrine nipple sores. Consistent over-term out-of androgen receptor followed closely by the increased loss of estrogen and you can progesterone receptors when you look at the apocrine metaplasia and apocrine carcinoma during the situ. Pathol Res Pract. 1997, 193 (11-12): 753-758.

Are J Clin Pathol

Soreide JA, Lea OA, Varhaug JE, Skarstein An effective, Kvinnsland S: Androgen receptors for the operable cancer of the breast: reference to almost every other steroid hormones receptors, correlations in order to prognostic circumstances and you will predictive value having effectation of additive tamoxifen procedures. Eur J Surg Oncol. 1992, 18 (2): 112-118.

Bayer-Gather IB, Smoller B: Androgen receptors: an effective marker to improve sensitiveness to have determining breast cancer inside the facial skin metastasis out of unfamiliar pri, thirteen (2): 119-122. /modpathol.3880021.

Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic craft and you can health-related ramifications. J Clin Oncol. 2000, 18 (5): 1135-1149.

Pang ST, Flores-Morales Good, Skoog L, Chuan YC, Nordstedt G, Pousette A good: Controls off matrix metalloproteinase 13 expression by the androgen in prostate disease. Oncol Agent. 2004, 11 (6): 1187-1192.

Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer. 1984, 54 (11): 2436-2440. -0142(19841201)<2436::AID-CNCR2820541121>3.0.

Schippinger W, Regitnig P, Dandachi Letter, Wernecke KD, Bauernhofer T, Samonigg H, Moinfar F: Evaluation of one’s prognostic significance of androgen receptor phrase in the metastatic cancer of the breast. Virchows Arc. 2006, 449 (1): 24-29. /s00428-006-0213-six.

Parker RL, Huntsman DG, Lesack DW, Cupples JB, Grant DR, Akbari M, Gilks CB: Investigations of interlaboratory adaptation throughout the immunohistochemical dedication of the hormone estrogen receptor standing using a cancer of the breast tissues microarray. 2002, 117 (5): 723-728. /PEF8-GL6F-YWMC-AG56.

Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, , Garcia-Muniz JL: Examination of matrix metalloproteinases and their inhibitors for the breast cancer. Br J Malignant tumors. 2007, 96 (6): 903-911. /sj.bjc.6603666.

Narita D, Raica Yards, Suciu C, Cimpean A, Anghel A great: Immunohistochemical expression off androgen receptor and you may prostate-certain antigen during the cancer of the breast. Folia Histochem Cytobiol. 2006, forty-two (3): 165-172.

Egeblad Meters, Werb Z: The fresh services for the matrix metalloproteinases inside the cancers progression. Nat Rev Cancer. 2002, dos (3): 161-174. /nrc745.

Turk V, Kos J, Turk B: Cysteine cathepsins (proteases)–on fundamental stage off cancer tumors?. Disease Cell. 2004, 5 (5): 409-410. /S1535-6108(04)00117-5.

Manes S, Llorente M, Lacalle RA, Gomez-Mouton C, Kremer L, Mira Elizabeth, Martinez Air conditioning: Brand new matrix metalloproteinase-nine regulates the brand new insulin-such as for instance gains foundation-triggered autocrine response when you look at the DU-145 carcinoma tissue. J Biol Chem. 1999, 274 (11): 6935-6945. /jbc..

Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel Age, Matrisian LM, Mareel Yards: Launch of an invasion supporter Elizabeth-cadherin fragment from the matrilysin and you may stromelysin-step one. J Telephone Sci. 2001, 114 (Pt step 1): 111-118.

Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM: Matrilysin [MMP-7] phrase picks to own tissues with just minimal susceptibility to apoptosis. Neoplasia. 2001, 3 (6): 459-468. /sj.neo.7900190.


Stetler-Stevenson WG: Matrix metalloproteinases from inside the angiogenesis: a moving address for therapeutic intervention. J Clin Invest. 1999, 103 (9): 1237-1241. /JCI6870.

Cornelius La, Nehring LC, Harding Elizabeth, Bolanowski M, Welgus HG, Kobayashi DK, Pierce RA, Shapiro SD: Matrix metalloproteinases build angiostatin: consequences for the neovascularization. J Immunol. 1998, 161 (12): 6845-6852.

Jiang Y, Goldberg ID, Shi YE: State-of-the-art positions out-of structure inhibitors off metalloproteinases into the cancer. Oncogene. 2002, 21 (14): 2245-2252. /sj.onc.1205291.

Leave a Reply